Zymeworks (ZYME) Shares Outstanding (Weighted Average) (2021 - 2026)

Zymeworks' Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $74.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 0.67% year-over-year to $74.7 million; the TTM figure through Mar 2026 stood at $74.7 million (down 0.67% YoY), while the FY2025 annual figure was $75.4 million, down 0.58% from the prior year.
• Shares Outstanding (Weighted Average) came in at $74.7 million for Q1 2026 at Zymeworks, down from $75.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $76.3 million in Q2 2024 to a low of $61.4 million in Q1 2022.
• A 5-year average of $71.3 million and a median of $74.7 million in 2026 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 26.46% in 2022 and retreated 1.37% in 2025, its largest moves.
• Zymeworks' Shares Outstanding (Weighted Average) stood at $65.2 million in 2022, then grew by 5.63% to $68.9 million in 2023, then increased by 10.14% to $75.8 million in 2024, then retreated by 0.58% to $75.4 million in 2025, then declined by 0.98% to $74.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $74.7 million, $75.4 million, and $75.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison